Study Details
A First in Man Study to determine the safety at various dose levels of AGS-16M8F in Advanced Kidney Cancer
Clinicaltrials.gov ID
Astellas Study ID
2009002
EudraCT ID
N/A
Condition
Kidney Cancer, Other
Phase
Phase 1
Age
18 Years - N/A
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Aug 2010 - Nov 2012
Masking
None (Open Label)
Enrollment number
26
A Phase 1, Open-label, Multi-center, Dose Escalation Study of the Safety and Pharmacokinetics of AGS-16M8F Monotherapy in Subjects with Advanced Renal Cell Carcinoma
Study summary
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A First in Man Study to determine the safety at various dose levels of AGS-16M8F in Advanced Kidney Cancer? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Seattle Cancer Care Alliance
Seattle, United States, 98109
Memorial Sloan Kettering Cancer Center
New York, United States, 10021
Dana-Farber Cancer Institute
Boston, United States, 02115